October 1, 2025
Authored and Edited by Forrest A. Jones; Jameson K. Gardner, Ph.D.; Comfort O. Adeyemi
Acting Director Coke Morgan Stewart denied institution of all six Petitions in Amazon.com, Inc., Amazon.com Services LLC, Amazon Web Services, Inc., and Audible, Inc. v. Audio Pod IP, LLC, IPR2025-00757, IPR2025-00765, IPR2025-00768, IPR2025-00769, IPR2025-00774, IPR2025-00777, Paper 15 (PTAB Aug.14, 2025) on the basis of efficient use of Board resources, even though one of the challenged patents had only been in force since 2020.
At the time of the decision, five of the challenged patents had been in force for at least seven years, while the sixth—U.S. Patent No. 10,805,111 (“the ’111 patent”)—had been in force for four years. For the five older patents, the Acting Director found that their age created “strong settled expectations” and that Petitioners had been aware of these patents for a significant period before filing their Petitions. While acknowledging that the shorter enforcement period for the ’111 patent would typically weigh against discretionary denial, the Acting Director explained that instituting a separate IPR solely for the ’111 patent would have been an “inefficient use of Board resources.” The Acting Director also noted that all six patents were the subject of a parallel district court case, and as such, the validity of the patents would be assessed in that proceeding.
In contrast to Amgen Inc. v. Bristol-Myers Squibb Company, IPR2025-00603, Paper 8 (PTAB Jul. 24, 2025), where institution was denied for two patents that were at least six years old but a third patent that was only three years old was referred to the Board because it had not yet developed “strong settled expectations,” here, the Acting Director did not determine whether the ’111 patent had itself developed strong settled expectations. Instead, the Acting Director determined that institution would not be an efficient use of Board resources despite the lack of settled expectations for the ’111 patent, suggesting that related patents may sometimes rise and fall together, regardless of age.
Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.